Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies

TOP News

Vialek Book Banner

Oasmia Pharma’s cancer drug received marketing approval in Kazakhstan

pharmacy
Oasmia Pharmaceutical announced that it has received marketing approval for Paclical in Kazakhstan

Cardiome Pharma brings Aggrastat to Russian market

cardiology
Cardiome Pharma announced that its affiliate Correvio has entered into an exclusive license and distribution agreement with ZAO Firma Euroservice

AstraZeneca conducts 45 clinical trials of its medicinal products in Russia

astrazeneca
The General Director of AstraZeneca Russia & Eurasia said that the company is one of the global market leaders in terms of the relative investments in R&D

Commercial manufacturing was launched at Novartis Neva plant

novartis
The Vice-Governor of St. Petersburg and The President of Novartis Group in Russia launched the commercial manufacturing of Ketonal® DUO

OncoTartis will develop a fundamentally new oncological drug

research
OncoTartis Inc., an American subsidiary of OncoTartis, a resident of SKOLKOVO, raised $6 million to develop a drug for the treatment of acute leukemia

Bone Therapeutics and Cellthera Pharm intend to cooperate

microscope
Bone Therapeutics and Cellthera Pharm today announced the intention to collaborate in the field of cell-based therapies for orthopaedics and bone diseases

CTI Clinical Trial and Consulting Services buys Eurotrials

clinical trials
CTI Clinical Trial and Consulting Services announced the acquisition of Eurotrials, a full-service contract research organization

Subscribe to GMP news Newsletter!

Pharmcontract Banner

Interview

National producers entered the market with nearly a dozen of biosimilars

Denis Manturov
Denis Manturov told the correspondent of "Expert" magazine how the Ministry for Industry & Trade continues to work towards technical upgrading of the Russian industry, about current progress in th...

The long and expensive process to enter the international market

Nikolai Yemelianov - Niarmedic Plus
What is the difference between the native antiviral drugs and imported ones and what is necessary for their entry into foreign markets, described the head of the Department of medical research and inf...

Modern Russian enterprises are not inferior in terms of quality to the foreign facilities

Shestakov
The 19th International Exhibition of equipment, raw materials and technologies for pharmaceutical production – Pharmtech & Ingredients 2016 – was held on November 22-25, 2016.   On the first da...

Subscribe to GMP news Newsletter!

Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies